The results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest the immune systems of people infected with COVID-19 may rely on antibodies ...
Jan 19, 2021
0
663
People in nursing homes have been suffering in isolation during the coronavirus pandemic, with their institutions in constant lockdown to prevent potentially fatal outbreaks.
Jan 19, 2021
0
1
The SARS-CoV-2 virus that is causing the COVID-19 pandemic is just one of many different viruses in the coronavirus family. Many of these are circulating in populations of animals like bats and have the potential to "jump" ...
Jan 12, 2021
0
335
The Asian tiger mosquito does not pose a major risk for Zika virus epidemics, according to a study published December 31 in the open-access journal PLOS Pathogens by Albin Fontaine of the Institut de Recherche Biomédicale ...
Dec 31, 2020
0
39
Late-onset Alzheimer's disease (LOAD) is the most common form of dementia in the elderly, affecting almost 44 million people worldwide. Despite decades of research, genetic factors that predispose individuals to LOAD are ...
Dec 8, 2020
0
22
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found. The ...
Dec 7, 2020
0
686
While many scientists are racing to find vaccines to tame the spread of the coronavirus pandemic, other researchers are probing the past, trying to unravel one of the greatest mysteries of the virus: exactly where it came ...
Dec 1, 2020
2
4
Rotavirus is a major cause of diarrhea and vomiting, especially in children, that results in approximately 128,000 deaths annually. The virus triggers the disease by infecting enterocyte cells in the small intestine, but ...
Nov 20, 2020
0
56
New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications ...
Nov 19, 2020
0
13
Scientists from the University of Oxford, working as part of the EBOVAC2 EBL2001 study group, have today announced the results of a phase 2 trial of a replication-deficient adenovirus vaccine aimed at providing protection ...
Nov 18, 2020
0
8
